First off let me thank you for your postings. Yes we are in agreement on the wise spending,I would prefer investing however. Just to emphasize the relationship of pay and performance, P. Michael Formica earned $533k last year as Exec. V.P. of Operations, now if his responsibilities covers manufacturing, we heard through the conference call how due to the ramp up of UPT and consequently the problem with spoilage and defects this effected the botton line in a negative material manner, one would hope that such management would perform duties with more acumen and effect the bottom line in a postive material manner. Now as far as their product line, it amazes me how very little the general public knows of oral testing, and again the Exec V.P. of Sales and Marketing Joseph Zack pulls down a respectable $395k, and todate nary a comprehensive international plan to market these wonderful products. And the Exec V.P./CFO Ronald C. Spair earned a healthy $557k and has the dubious job of paying hundreds of thousands of dollars to have a business strategy plan drown up soon when today is far to delinquent and somewhat under his job description. And lastly the double CEO salary for a full year, I gues like the NBA the company must of negotiated with a sports agent when signing Gausling up, guaranteed even though retired, injured or in drug rehab.
The strategic business plan consultants are going to cost upwards of a few hundred thousand dollars, which leads again to ask why the f*ck is this administration bleeding the company into continuous losses and still blathering about seeking, developing, discussing....ing...ing...ing.....losing. Some one tell me why does Ron Spair and Mike Gaulsing garnish such generous salaries?